BASKING RIDGE, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the ...

BASKING RIDGE, N.J. and SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (LSTA) (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the ...

BASKING RIDGE, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of ...

BASKING RIDGE, N.J., April 27, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the ...

If you’re interested in Caladrius Biosciences Inc (NASDAQ:CLBS), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your ...

The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., (Caladrius)(Nasdaq: CLBS), has reached the halfway point for ...

* Caladrius Biosciences Inc says expects to reach important milestone of treating 50% of subjects by mid-2017 * Caladrius Biosciences Inc says enrollment of 70 subject in study, expected to occur in ...

Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select therapeutic development pipeline, has licensed to ...

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Indices Commodities Currencies Stocks ...

* Caladrius Biosciences announces addition of three clinical sites, including university of California, San Francisco, for the ongoing Phase 2 study of CLBS03 in T1D Sign up here. * Caladrius ...

Mr. Schloss most recently served as vice president of HR at clinical stage cell therapy company Caladrius Biosciences, formerly NeoStem. He maintains more than 25 years of experience in HR, spanning ...